SCHEMBL5429907

SCHEMBL5429907

C=CCC(C(=O)O)(C(=O)OC(C)CC)C(C[N+](=O)[O-])c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.48
CYP3A4 P08684 1/20 0.48
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 2/20 0.31
CPA1 P15085 4/20 0.31
POLB P06746 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
NPC1 O15118 1/20 0.30
ADAM17 P78536 1/20 0.30
PTGS1 P23219 1/20 0.30
PTGS2 P35354 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14359432 0.81 ALDH1A1 (0.53) ALDH1A1CYP3A4MAPTLMNAGAA
SCHEMBL5435120 0.81 ALDH1A1 (0.53) ALDH1A1CYP3A4MAPTLMNAGAA
SCHEMBL5429900 0.81 ALDH1A1 (0.53) ALDH1A1CYP3A4MAPTLMNAGAA
SCHEMBL578529 0.73 ALDH1A1 (0.56) ALDH1A1CYP3A4MAPTLMNATSHR
SCHEMBL4750086 0.68 ALDH1A1 (0.49) ALDH1A1CYP3A4MAPTKDM4ECPA1
SCHEMBL6227187 0.66 ALDH1A1 (0.62) ALDH1A1CYP3A4CPA1NPC1ADAM17
SCHEMBL3519696 0.66 KDM4E (0.31) ALDH1A1KDM4ELMNAGLAGAA
SCHEMBL578528 0.66 ALDH1A1 (0.44) ALDH1A1CYP3A4MAPTLMNACYP2C19
SCHEMBL5806972 0.66 ALDH1A1 (0.32) ALDH1A1MAPTKDM4ELMNAGLA
SCHEMBL4302729 0.66 ALDH1A1 (0.65) ALDH1A1CYP3A4CPA1NPC1ADAM17

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070276145-A1 Method of Preparing a Ring Compound Having Two Adjacent Chiral Centers ICOS CORPORATION (US) 2007-11-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070276145-A1 Method of Preparing a Ring Compound Having Two Adjacent Chiral Centers NISCH, NDC1, SUCLG2 ALDH1A1 1567/4885CYP3A4 902/4885MAPT 3548/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.